2-piperidone has been researched along with Colonic Neoplasms in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Alburquerque-González, B; Bernabé-García, Á; Bernabé-García, M; Cayuela, ML; Conesa-Zamora, P; López-Calderón, FF; Luque, I; Montoro-García, S; Nicolas, FJ; Pérez-Sánchez, H; Rodrigues, PC; Ruiz Sanz, J; Salo, T | 1 |
Addala, E; Bandy, B; Das, S; Das, U; Dimmock, JR; Karki, SS; Rafiei, H | 1 |
Bognár, B; Hideg, K; Kálai, T; Kuppusamy, ML; Kuppusamy, P; Prabhat, AM | 1 |
Brnjic, S; D'Arcy, P; Hillert, EK; Linder, S; Mazurkiewicz, M; Mofers, A; Saei, AA; Selvaraju, K; Zhang, X; Zubarev, R | 1 |
Das, S; Das, U; Dimmock, JR; Gorecki, DK; Michel, D | 1 |
Bessa, C; Bisio, A; Fernandes, J; Gomes, C; Gomes, S; Gonçalves, J; Inga, A; Monteiro, Â; Pereira, C; Pereira, NA; Queiroz, G; Raimundo, L; Reis, F; Santos, MM; Saraiva, L; Soares, J | 1 |
Das, U; Dimmock, JR; Lakshmikuttyamma, A; Pati, HN; Selvakumar, P; Sharma, RK | 1 |
Bandy, B; Das, U; Dimmock, JR; Helal, M; Islam, A; Nazarali, AJ | 1 |
Akagi, Y; Araki, Y; Hara, H; Kumabe, T; Matono, K; Ogata, Y; Saitsu, H; Sata, M; Shirouzu, K; Tsuda, H | 1 |
Burzynski, SR | 1 |
Anant, S; Dieckgraefe, BK; George, R; Hideg, K; Houchen, CW; Kuppusamy, P; Lee, KB; May, R; Ramanujam, RP; Subramaniam, D; Sureban, SM | 1 |
1 review(s) available for 2-piperidone and Colonic Neoplasms
Article | Year |
---|---|
The present state of antineoplaston research (1).
Topics: Adenocarcinoma; Benzeneacetamides; Brain Neoplasms; Child; Clinical Trials as Topic; Colonic Neoplasms; Complementary Therapies; Gene Expression Profiling; Gene Expression Regulation; Genes, p53; Glioma; Humans; Piperidones; Survival Analysis | 2004 |
10 other study(ies) available for 2-piperidone and Colonic Neoplasms
Article | Year |
---|---|
New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells.
Topics: Animals; Antidepressive Agents; Carrier Proteins; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Imipramine; Macrolides; Microfilament Proteins; Neoplasm Invasiveness; Piperidones; Zebrafish | 2020 |
3,5-Bis(3-dimethylaminomethyl-4-hydroxybenzylidene)-4-piperidone and related compounds induce glutathione oxidation and mitochondria-mediated cell death in HCT-116 colon cancer cells.
Topics: Apoptosis; Cell Line; Colonic Neoplasms; Curcumin; Glutathione; HCT116 Cells; Humans; Membrane Potential, Mitochondrial; Mitochondria; Oxidation-Reduction; Piperidones; Reactive Oxygen Species; Superoxides | 2017 |
Antiproliferative Effect of a Novel 4,4'-Disulfonyldiarylidenyl Piperidone in Human Colon Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Colonic Neoplasms; Curcumin; Electron Spin Resonance Spectroscopy; HCT116 Cells; Humans; Phosphorylation; Piperidones; Reactive Oxygen Species; STAT3 Transcription Factor; Tumor Suppressor Protein p53 | 2019 |
Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation.
Topics: Apoptosis; Bortezomib; Cell Death; Cell Line, Tumor; Colonic Neoplasms; Endoplasmic Reticulum Stress; Histone Deacetylase Inhibitors; Humans; Piperidones; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteolysis; Ubiquitin | 2019 |
Novel 3,5-bis(arylidene)-4-piperidone dimers: potent cytotoxins against colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Dimerization; Dose-Response Relationship, Drug; Drug Discovery; HCT116 Cells; HT29 Cells; Humans; Molecular Structure; Piperidones; Quantitative Structure-Activity Relationship; Tumor Cells, Cultured | 2013 |
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Colonic Neoplasms; High-Throughput Screening Assays; Humans; Immunoenzyme Techniques; Isoindoles; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Oxazoles; Piperidones; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Small Molecule Libraries; Tryptophan; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |
NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells.
Topics: Aminopeptidases; Apoptosis; Blotting, Western; Cell Cycle; Cell Division; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; G2 Phase; Glycoproteins; HT29 Cells; Humans; Methionyl Aminopeptidases; Molecular Structure; Phosphorylation; Piperidones; Proto-Oncogene Proteins pp60(c-src); Sulfonic Acids | 2009 |
Mitochondrial dysfunction contributes to the cytotoxicity of some 3,5-bis(benzylidene)-4-piperidone derivatives in colon HCT-116 cells.
Topics: Animals; Colonic Neoplasms; Glutathione; HCT116 Cells; Humans; Membrane Potential, Mitochondrial; Mitochondria; Piperidones; Reactive Oxygen Species | 2013 |
Long-term survival following treatment with antineoplastons for colon cancer with unresectable multiple liver metastases: report of a case.
Topics: Adenocarcinoma; Aged; Benzeneacetamides; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Electrocoagulation; Humans; Liver Neoplasms; Male; Microwaves; Piperidones; Prognosis; Survivors | 2003 |
Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity.
Topics: Adenocarcinoma; Animals; Apoptosis; Benzylidene Compounds; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; HCT116 Cells; HT29 Cells; Humans; Interleukin-8; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Neovascularization, Pathologic; Piperidones; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |